Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Change in Receivables (2017 - 2025)

Historic Change in Receivables for Catheter Precision (VTAK) over the last 9 years, with Q3 2025 value amounting to $8000.0.

  • Catheter Precision's Change in Receivables rose 30000.0% to $8000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $16000.0, marking a year-over-year decrease of 7377.05%. This contributed to the annual value of -$67000.0 for FY2024, which is 20151.52% down from last year.
  • Catheter Precision's Change in Receivables amounted to $8000.0 in Q3 2025, which was up 30000.0% from $29000.0 recorded in Q2 2025.
  • Catheter Precision's Change in Receivables' 5-year high stood at $91000.0 during Q4 2023, with a 5-year trough of -$83000.0 in Q3 2021.
  • In the last 5 years, Catheter Precision's Change in Receivables had a median value of $9000.0 in 2022 and averaged $1722.2.
  • In the last 5 years, Catheter Precision's Change in Receivables tumbled by 840000.0% in 2021 and then soared by 33333.33% in 2023.
  • Over the past 5 years, Catheter Precision's Change in Receivables (Quarter) stood at $51000.0 in 2021, then plummeted by 66.67% to $17000.0 in 2022, then skyrocketed by 435.29% to $91000.0 in 2023, then crashed by 140.66% to -$37000.0 in 2024, then skyrocketed by 121.62% to $8000.0 in 2025.
  • Its last three reported values are $8000.0 in Q3 2025, $29000.0 for Q2 2025, and $16000.0 during Q1 2025.